Ubaldo Bonuccelli

Prof. Ubaldo Bonuccelli


Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2007 in The Lancet Neurology
Verified
Journal Article
Closed access
IMIan McKeith
Ian McKeith
JOJohn O'Brien
John O'Brien
ZWZuzana Walker
Zuzana Walker
KTKlaus Tatsch
Klaus Tatsch
JBJan Booij
Jan Booij
CRCornelia Reininger
Cornelia Reininger

1 June 2007 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
PMPablo Martinez‐Martin
Pablo Martinez‐Martin
ASAnthony Schapira
Anthony Schapira
FSFabrizio Stocchi
Fabrizio Stocchi
KSKapil Sethi
Kapil Sethi
POPer Odin
Per Odin
Kallol (K) Chaudhuri also Ray-ChaudhuriKallol (K) Chaudhuri also Ray-Chaudhuri
Kallol (K) Chaudhuri also Ray-Chaudhuri

1 October 2010 in The Lancet Neurology
Verified
Journal Article
Closed access
MEMurat Emre
Murat Emre
Magda TsolakiMagda Tsolaki
Magda Tsolaki
UBUbaldo Bonuccelli
Ubaldo Bonuccelli
ADAlain Destée
Alain Destée
ETEduardo Tolosa
Eduardo Tolosa
RJRoy Jones
Roy Jones

13 August 2014 in JAMA
Verified
Journal Article
Open access
PDF file
GGGino Gialdini
Gino Gialdini
KNKatherine Nearing
Katherine Nearing
PBPrashant D. Bhave
Prashant D. Bhave
UBUbaldo Bonuccelli
Ubaldo Bonuccelli
CICostantino Iadecola
Costantino Iadecola
HKHooman Kamel
Hooman Kamel
Atrial fibrillation (AF) and flutter affect more than 33 million people worldwide.1 The presence of chronic AF confers a 3-fold increased risk of stroke, and stroke in patients with AF is associated with a longer hospital stay, greater disability, and increased mortality compared with other types of ischemic stroke.2

22 December 2012 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
Joaquim FerreiraJoaquim Ferreira
Joaquim Ferreira
RKR. Katzenschlager
R. Katzenschlager
BBB. R. Bloem
B. R. Bloem
UBUbaldo Bonuccelli
Ubaldo Bonuccelli
DBD. Burn
D. Burn
WOW. H. Oertel
W. H. Oertel
Objective: To summarize the 2010 EFNS/MDS‐ES evidence‐based treatment recommendations for the management of Parkinson's disease (PD). This summary includes the treatment recommendations for early and late PD.Methods: For the 2010 publication, a literature search was undertaken for articles published up to September 2009. For this summary, an additional literature search was undertaken up to December 2010. Classification of scientific evidence and the rating of recommendations were made according to the EFNS guidance. In cases where there was insufficient scientific evidence, a consensus statement (‘good practice point’) is made.Results and Conclusions: For each clinical indication, a list of therapeutic interventions is provided, including classification of evidence.

1 September 2008 in Archives of Neurology
Verified
Journal Article
Open access
PDF file
GDGiovanni Defazio
Giovanni Defazio
ABAlfredo Berardelli
Alfredo Berardelli
GFGiovanni Fabbrini
Giovanni Fabbrini
DMDavide Martino
Davide Martino
EFEmiliana Fincati
Emiliana Fincati
MTMichele Tinazzi
Michele Tinazzi
Patients with Parkinson disease (PD) often complain of painful sensations that may involve body parts affected and unaffected by dystonia.1-7 Pain in nondystonic body parts may have cramping and arthralgic features, as well as features of peripheral or central neuropathic pain.1,6 The high frequency of these pain disorders in the general population makes it hard to establish whether pain is more frequent among people with PD than among age-matched controls. Although the 3 pertinent controlled studies (1 published in abstract form alone)5-7 found a higher frequency of pain among PD patients than among controls, they provided inconclusive results, owing to limitations in study design. Most important, they failed to distinguish between dystonic and nondystonic pain, used as controls a relatively small group of participants with diseases who may not have fully represented the variable of interest in the source population, and did not take into account the time between pain and PD onset.5,6 Finally, 2 of 3 studies focused on back pain alone.5,6